Fingolimod (FTY720) v. Placebo in Patients w/Relapsing MS
ID Number 06-0920Principal Investigator(s)
Department(s) or Division(s)
The main purpose of this study is to evaluate how effective fingolimod is in reducing the number of relapses and in delaying disability progression in patients with relapsing-remitting MS.
Recruiting Patients: No